HIV prevalence and HIV clinical outcomes of transgender and gender‐diverse people in England

Abstract

Objectives We provide the first estimate of HIV prevalence among trans and gender-diverse people living in England and compare outcomes of people living with HIV according to gender identity. Methods We analysed a comprehensive national HIV cohort and a nationally representative self-reported survey of people accessing HIV care in England (Positive Voices). Gender identity was recorded using a two-step question co-designed with community members and civil society. Responses were validated by clinic follow-up and/or self-report. Population estimates were obtained from national government offices. Results In 2017, HIV prevalence among trans and gender-diverse people was estimated at 0.46–4.78 per 1000, compared with 1.7 (95% credible interval: 1.6–1.7) in the general population. Of 94 885 people living with diagnosed HIV in England, 178 (0.19%) identified as trans or gender-diverse. Compared with cisgender people, trans and gender-diverse people were more likely to be London residents (57% vs. 43%), younger (median age 42 vs. 46 years), of white ethnicity (61% vs. 52%), under psychiatric care (11% vs. 4%), to report problems with self-care (37% vs. 13%), and to have been refused or delayed healthcare (23% vs . 11%). Antiretroviral uptake and viral suppression were high in both groups. Conclusions HIV prevalence among trans and gender-diverse people living in England is relatively low compared with international estimates. Furthermore, no inequalities were observed with regard to HIV care. Nevertheless, trans and gender-diverse people with HIV report poorer mental health and higher levels of discrimination compared with cisgender people.

Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data

“…Increased prevalence, incidence, and diagnosis of HIV infection may be due to engaging in condomless sexual intercourse, possibly in the context of survival sex work and/or injection drug use. 38 – 40 The population included in the present study had a low overall prevalence of HIV compared with national estimates of 0.46–4.78 per 1000 TSG persons, 41 likely due to the study population being engaged with primary care and potentially more aware of prevention measures. However, these data suggest that the HIV and hepatitis C epidemics for TGD persons, particularly transfeminine individuals, are still ongoing and that targeted interventions are needed to reduce the number of newly acquired infections each year.…”

A Science Mapping Analysis of Sixty-Seven Years of Scientific Evolution about the Transgender Population

“…During this period a large number of studies on HIV emerged, reflecting the exponential increase in the number of people infected by the virus in 2010. Although the number of infected transsexuals is lower than in the general population, they report greater psychological distress and higher levels of discrimation when compared to cisgenders [124]. Beyond that, discrimination can generate processes of physical and psychological illness and lead the individual to social vulnerability [125].…”

Empathy as a crucial skill in disrupting disparities in global brain health

“…Unjustified and avoidable differences in race/ethnicity, gender, and class-based socioeconomic differences exist in many other neurological and mental health disorders across the globe (40)(41)(42)(43), with disparities started to emerge during early stages of brain development (44). The effects of these individual factors on brain health may be distinct and particularly robust on individuals with intersectional identities.…”